Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study of DA-020

NCT07402330 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT07402330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07402330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study of DA-020
Lead sponsor
Applied Biology, Inc.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
April 16, 2026
Completion date
November 30, 2026
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced alopecia, chemotherapy side effects